United Kingdom pharmaceutical company GlaxoSmithKline on Tuesday reported on its corporate responsibility activities in 2008 and 2009, including a commitment to cutting prices on patented medicines for poor countries. GSK’s recent public announcement on access to medicines has generated some goodwill for the company though public health advocates and observers have been cautious in their praise. GSK report here.
Intellectual Property Watch
Original news and analysis on international IP policy